Literature DB >> 18853979

Gastrointestinal and hepatic manifestations of sarcoidosis.

Ellen C Ebert1, Malca Kierson, Klaus D Hagspiel.   

Abstract

Sarcoidosis is a multisystem disease characterized by noncaseating granulomas in the affected organs, including skin, heart, nervous system, and joints. Diagnosis of sarcoidosis is generally based upon a compatible history, demonstration of granulomas in at least two different organs, negative staining and culture for acid fast bacilli, absence of occupational or domestic exposure to toxins, and lack of drug-induced disease. Involvement of the hollow organs is rare. Rather than being due to sarcoidosis, some reported mucosal lesions may simply have incidental granulomas. Extrinsic compression from lymphadenopathy can occur throughout the gastrointestinal tract. The stomach, particularly the antrum, is the most common extrahepatic organ to be involved, while the small bowel is the least common. Liver involvement frequently occurs and ranges from asymptomatic incidental granulomas to portal hypertension from granulomas in the portal triad, usually with relatively preserved liver function. CT scans show hepatosplenomegaly and adenopathy, followed in frequency by focal low-attenuation lesions of the liver and spleen. Ascites is usually a transudate from right heart failure (because of pulmonary hypertension) or portal hypertension (because of biliary cirrhosis). Rarely, an exudative ascites may occur from studding of the peritoneum with nodules. Pancreatic involvement presents as a mass, usually in the head or a diffusely firm, nodular organ. Corticosteroids should be instituted when organ function is threatened, usually lungs, eyes, and central nervous system. Their role in the treatment of hepatic sarcoidosis is unclear. The overall prognosis is good although most patients will have some permanent organ impairment. Cardiac and pulmonary diseases are the main causes of death.

Entities:  

Mesh:

Year:  2008        PMID: 18853979     DOI: 10.1111/j.1572-0241.2008.02202.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  55 in total

Review 1.  Granulomas in the gastrointestinal tract: deciphering the Pandora's box.

Authors:  Ian Brown; Marian Priyanthi Kumarasinghe
Journal:  Virchows Arch       Date:  2017-08-04       Impact factor: 4.064

Review 2.  Ileitis: when it is not Crohn's disease.

Authors:  Steven Dilauro; Nancy F Crum-Cianflone
Journal:  Curr Gastroenterol Rep       Date:  2010-08

3.  Peritoneal sarcoidosis: a unique cause of ascites and intractable hiccups.

Authors:  W Andrew Hackworth; Katherine N Kimmelshue; R Todd Stravitz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2009-12

4.  Peritoneal sarcoidosis: the role of imaging in diagnosis.

Authors:  Meghan G Lubner; Perry J Pickhardt
Journal:  Gastroenterol Hepatol (N Y)       Date:  2009-12

Review 5.  [Sarcoidosis].

Authors:  A Prasse; J Müller-Quernheim
Journal:  Internist (Berl)       Date:  2009-05       Impact factor: 0.743

Review 6.  New insights into gastrointestinal and hepatic granulomatous disorders.

Authors:  Majid A Almadi; Abdulrahman M Aljebreen; Faisal M Sanai; Victoria Marcus; Ebtissam S Almeghaiseeb; Subrata Ghosh
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-08-05       Impact factor: 46.802

Review 7.  Gastrointestinal and Hepatic Sarcoidosis: A Review Article.

Authors:  Neil Shah; Arnab Mitra
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-05-01

8.  Multisystemic Sarcoidosis with Early Gastrointestinal Symptoms.

Authors:  Catarina Mota; Carlos Ferreira; Maria Emília Oliveira; João Meneses Santos; Rui M M Victorino
Journal:  GE Port J Gastroenterol       Date:  2016-12-09

Review 9.  [Many faces of sarcoidosis].

Authors:  H Prosch; K Vonbank; C Loewe; D Beitzke
Journal:  Radiologe       Date:  2016-01       Impact factor: 0.635

Review 10.  Extrapulmonary manifestations of sarcoidosis.

Authors:  Deepak A Rao; Paul F Dellaripa
Journal:  Rheum Dis Clin North Am       Date:  2013-03-13       Impact factor: 2.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.